RET and multiple endocrine neoplasia type 2: For example, in genetic testing for multiple endocrine neoplasia type 2 (MEN2), clinical validity refers to robust evidence demonstrating that testing for RET mutations can accurately stratify a population into distinct groups based on their risk, with statistical significance, enabling early detection of affected family members before symptoms develop [312].